Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Lung Function versus Monotherapies in GOLD Category A Patients with COPD: Pooled Data from the Phase III PINNACLE Studies

Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Lung Function versus Monotherapies in GOLD Category A Patients with COPD: Pooled Data from the Phase III PINNACLE Studies

Fernando J Martinez,1 Klaus F Rabe,2 Brian J Lipworth,3 Samir Arora,4 Martin Jenkins,5 Ubaldo J Martin,6 Colin Reisner6,7 1Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, NY, USA; 2Department of Pneumonology, LungenClinic Grosshansdorf and Christian-Albrechts Univ...

Full description

Bibliographic Details
Main Authors: Martinez FJ, Rabe KF, Lipworth BJ, Arora S, Jenkins M, Martin UJ, Reisner C
Format: Article
Language:English
Published: Dove Medical Press 2020-01-01
Series:International Journal of COPD
Subjects:
β2-agonist
bronchodilator
copd
co-suspension delivery technology
lung function
muscarinic antagonist
Online Access:https://www.dovepress.com/glycopyrrolateformoterol-fumarate-metered-dose-inhaler-improves-lung-f-peer-reviewed-article-COPD

Internet

https://www.dovepress.com/glycopyrrolateformoterol-fumarate-metered-dose-inhaler-improves-lung-f-peer-reviewed-article-COPD

Similar Items